Alamar Biosciences, Inc. | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases Alamar Biosciences, Inc.

Home
Companies
Alamar Biosciences, Inc.

BRIEF

published on 10/15/2025 at 15:20, 1 month 20 days ago

Alamar Biosciences Strengthens Leadership for Growth

Leadership Changes Financial Strategy Growth And Innovation Precision Proteomics Alamar Biosciences
PRESS RELEASE

published on 10/15/2025 at 15:15, 1 month 20 days ago

Alamar Biosciences Expands Executive Leadership to Power Next Phase of Growth
Alamar Biosciences expands executive leadership team with Tod White as President and Justin McAnear as CFO to drive growth and innovation in precision proteomics for disease detection

Executive Leadership Precision Proteomics Alamar Biosciences Tod White Justin McAnear
BRIEF

published on 10/09/2025 at 23:25, 1 month 26 days ago

Alamar Biosciences Unveils Innovative Blood-Based Assay for Alzheimer's Research

Alzheimer's Research Neurodegenerative Diseases Blood-based Assay Biomarker Detection Precision Proteomics
PRESS RELEASE

published on 10/09/2025 at 23:20, 1 month 26 days ago

Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer's Disease Research
Alamar Biosciences launches NULISAqpcr™ BD-pTau217 Assay, a breakthrough in non-invasive, brain-specific biomarker detection for Alzheimer's disease research. The assay offers unparalleled sensitivity and CNS specificity, redefining biomarker quantitation

Alzheimer's Disease Biomarker Detection Precision Proteomics Alamar Biosciences NULISAqpcr BD-pTau217 Assay

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 47 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 52 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 22 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 17 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 22 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 52 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 31 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 57 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 7 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 11 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 22 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 37 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 38 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 21 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE